Zobrazeno 1 - 10
of 196
pro vyhledávání: '"Erica L, Carpenter"'
Autor:
Jacob E. Till, Lee McDaniel, Changgee Chang, Qi Long, Shannon M. Pfeiffer, Jaclyn P. Lyman, Lacey J. Padrón, Deena M. Maurer, Jia Xin Yu, Christine N. Spencer, Pier Federico Gherardini, Diane M. Da Silva, Theresa M. LaVallee, Charles Abbott, Richard O. Chen, Sean M. Boyle, Neha Bhagwat, Samuele Cannas, Hersh Sagreiya, Wenrui Li, Stephanie S. Yee, Aseel Abdalla, Zhuoyang Wang, Melinda Yin, Dominique Ballinger, Paul Wissel, Jennifer Eads, Thomas Karasic, Charles Schneider, Peter O’Dwyer, Ursina Teitelbaum, Kim A. Reiss, Osama E. Rahma, George A. Fisher, Andrew H. Ko, Zev A. Wainberg, Robert A. Wolff, Eileen M. O’Reilly, Mark H. O’Hara, Christopher R. Cabanski, Robert H. Vonderheide, Erica L. Carpenter
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-12 (2024)
Abstract While high circulating tumor DNA (ctDNA) levels are associated with poor survival for multiple cancers, variant-specific differences in the association of ctDNA levels and survival have not been examined. Here we investigate KRAS ctDNA (ctKR
Externí odkaz:
https://doaj.org/article/4f9cd688d606493b979047418e6f71a0
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-13 (2023)
Abstract The isolation of specific subpopulations of extracellular vesicles (EVs) based on their expression of surface markers poses a significant challenge due to their nanoscale size ( 10× relative to prior published designs without sacrificing re
Externí odkaz:
https://doaj.org/article/7fcbeb56f14445a2946ef7f48ef09d50
Autor:
Apurva Singh, Hannah Horng, Leonid Roshkovan, Joanna K. Weeks, Michelle Hershman, Peter Noël, José Marcio Luna, Eric A. Cohen, Lauren Pantalone, Russell T. Shinohara, Joshua M. Bauml, Jeffrey C. Thompson, Charu Aggarwal, Erica L. Carpenter, Sharyn I. Katz, Despina Kontos
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-12 (2022)
Abstract We aim to determine the feasibility of a novel radiomic biomarker that can integrate with other established clinical prognostic factors to predict progression-free survival (PFS) in patients with non-small cell lung cancer (NSCLC) undergoing
Externí odkaz:
https://doaj.org/article/56ec5c56ca4341e8ac7babf7c546c3c5
Autor:
Moen Sen, Ryan M. Hausler, Keely Dulmage, Taylor A. Black, William Murphy, Charles H. Pletcher Jr, Ling Wang, Chang Chen, Stephanie S. Yee, Scott J. Bornheimer, Kara N. Maxwell, Ben Z. Stanger, Jonni S. Moore, Jeffrey C. Thompson, Erica L. Carpenter
Publikováno v:
Clinical and Translational Medicine, Vol 12, Iss 7, Pp n/a-n/a (2022)
Externí odkaz:
https://doaj.org/article/0a106db67e8d471ba41b7ba01eec8319
Autor:
Bardia Yousefi, Michael J. LaRiviere, Eric A. Cohen, Thomas H. Buckingham, Stephanie S. Yee, Taylor A. Black, Austin L. Chien, Peter Noël, Wei-Ting Hwang, Sharyn I. Katz, Charu Aggarwal, Jeffrey C. Thompson, Erica L. Carpenter, Despina Kontos
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
Abstract Among non-small cell lung cancer (NSCLC) patients with therapeutically targetable tumor mutations in epidermal growth factor receptor (EGFR), not all patients respond to targeted therapy. Combining circulating-tumor DNA (ctDNA), clinical var
Externí odkaz:
https://doaj.org/article/2bc9f76cb0c2446eb992e36476f5b7bf
Autor:
Jeffrey C. Thompson, MD, MTR, Charu Aggarwal, MD, MPH, Janeline Wong, BS, Vivek Nimgaonkar, BS, Wei-Ting Hwang, PhD, Michelle Andronov, BS, David M. Dibardino, MD, Christoph T. Hutchinson, MD, MA, Kevin C. Ma, MD, Anthony Lanfranco, MD, MS, Edmund Moon, MD, Andrew R. Haas, MD, PhD, Aditi P. Singh, MD, Christine A. Ciunci, MD, MSCE, Melina Marmarelis, MD, MSCE, Christopher D’Avella, MD, Justine V. Cohen, DO, Joshua M. Bauml, MD, Roger B. Cohen, MD, Corey J. Langer, MD, Anil Vachani, MD, MSCE, Erica L. Carpenter, MBA, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 4, Pp 100301- (2022)
Introduction: The availability of targeted therapies has transformed the management of advanced NSCLC; however, most patients do not undergo guideline-recommended tumor genotyping. The impact of plasma-based next-generation sequencing (NGS) performed
Externí odkaz:
https://doaj.org/article/1e4a79ab12aa4b34955ec3972d774b0c
Autor:
Vivek Nimgaonkar, Jeffrey C. Thompson, Lauren Pantalone, Tessa Cook, Despina Kontos, Anne Marie McCarthy, Erica L. Carpenter
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
We investigated racial disparities in a 30-day composite outcome of readmission and death among patients admitted across a 5-hospital health system following an index COVID-19 admission. A dataset of 1,174 patients admitted between March 1, 2020 and
Externí odkaz:
https://doaj.org/article/d32439e29e054ea598553a2e6cc0921f
Autor:
Max M. Wattenberg, Veronica M. Herrera, Michael A. Giannone, Whitney L. Gladney, Erica L. Carpenter, Gregory L. Beatty
Publikováno v:
JCI Insight, Vol 6, Iss 5 (2021)
Agonistic anti-CD40 monoclonal antibody (mAb) therapy in combination with chemotherapy (chemoimmunotherapy) shows promise for the treatment of pancreatic ductal adenocarcinoma (PDA). To gain insight into immunological mechanisms of response and resis
Externí odkaz:
https://doaj.org/article/530321151d0149bdb9993c0278786f9e
Autor:
Mark Jesus M. Magbanua, Laura van ‘t Veer, Amy S. Clark, A. Jo Chien, Judy C. Boughey, Hyo S. Han, Anne Wallace, Heather Beckwith, Minetta C. Liu, Christina Yau, E. Paul Wileyto, Andrea Ordonez, Tulasi I. Solanki, Feng Hsiao, Jen Chieh Lee, Amrita Basu, Lamorna Brown Swigart, Jane Perlmutter, Amy L. Delson, Lauren Bayne, Shannon Deluca, Stephanie S. Yee, Erica L. Carpenter, Laura J. Esserman, John W. Park, Lewis A. Chodosh, Angela DeMichele
Publikováno v:
Breast Cancer Research and Treatment. 198:383-390
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d5d9594333706082d8c23f09f69d3ae
https://doi.org/10.1007/s10549-022-06803-0
https://doi.org/10.1007/s10549-022-06803-0
Autor:
William J. Chapin, Jacob E. Till, Wei-Ting Hwang, Jennifer R. Eads, Thomas B. Karasic, Peter J. O'Dwyer, Charles J. Schneider, Ursina R. Teitelbaum, Janae Romeo, Taylor A. Black, Theresa E. Christensen, Colleen Redlinger Tabery, Amanda Anderson, Megan Slade, Michael LaRiviere, Stephanie S. Yee, Kim A. Reiss, Mark H. O'Hara, Erica L. Carpenter
Publikováno v:
JCO precision oncology. 6
PURPOSE Pancreatic ductal adenocarcinoma (PDAC) is associated with a poor prognosis. Multianalyte signatures, including liquid biopsy and traditional clinical variables, have shown promise for improving prognostication in other solid tumors but have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69b5c3a9a69c1348cb58b0dfe0498373
https://pubmed.ncbi.nlm.nih.gov/35939771
https://pubmed.ncbi.nlm.nih.gov/35939771